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Our understanding of the molecular mechanisms that operate during differentiation of mitotically dividing spermatogonia cells into
spermatocytes lags way behind what is known about other differentiating systems. Given the evolutionary conservation of the meiotic
process, we screened for mouse proteins that could specifically activate early meiotic promoters in Saccharomyces cerevisiae yeast cells,
when fused to the Gal4 activation domain (Gal4AD). Our screen yielded the Aym1 gene that encodes a short peptide of 45 amino acids. We
show that a Gal4AD–AYM1 fusion protein activates expression of reporter genes through the promoters of the early meiosis-specific genes
IME2 and HOP1, and that this activation is dependent on the DNA-binding protein Ume6. Aym1 is transcribed predominantly in mouse
primary spermatocytes and in gonads of female embryos undergoing the corresponding meiotic divisions. Aym1 immunolocalized to nuclei
of primary spermatocytes and oocytes and to specific type A spermatogonia cells, suggesting it might play a role in the processes leading to
meiotic competence. The potential functional relationship between AYM1 and yeast proteins that regulate expression of early meiotic genes
is discussed.
D 2004 Elsevier Inc. All rights reserved.
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Roughly one out of eight people worldwide suffer from
some degree of fertility problems. Among these, a signifi-
cant number of cases are caused by severe defects in the
process of germ cell production (gametogenesis) and are
rather hard to deal with. The essence of gamete production
is meiosis, a process in which the number of chromosomes
in the gametes is reduced by half, so that during sexual
reproduction a new diploid organism is formed. Inability to
either enter or complete meiosis will ultimately cause
infertility.0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.08.026
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Center, Tel Aviv 64239, Israel.In mammals, the molecular machinery that activates
entry into and progression through meiosis is largely
unknown. A major limitation in identifying and studying
mammalian genes and factors that are involved in early
meiotic processes is the lack of an efficient and widely
accepted cell culture system that supports germ cell differ-
entiation in vitro. However, the molecular mechanisms that
regulate the transition from mitotically dividing cells to
entry into meiosis have been studied in most detail in the
yeast Saccharomyces cerevisiae (S. cerevisiae). In this
yeast, entry into meiosis is regulated by two major factors:
a genetic factor (the cell type) and an environmental factor
(the nutritional state of the cell). Only diploid cells with the
a1/a2 genotype at theMAT locus can enter meiosis and only
after being subjected to starvation conditions, i.e., nitrogen
depletion and a nonfermentable carbon source such as
acetate (reviewed in Kassir et al., 2003; Vershon and Pierce,276 (2004) 111–123
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ways converge at the regulation of the expression of early
meiotic genes. In vegetative cells (haploid or diploid), the
early meiotic genes are negatively regulated by two
complexes, which are recruited to their promoters through
the DNA-binding protein, Ume6: (1) The H DAC complex,
composed of the corepressor Sin3 and the Rpd3 histone
deacetylase (Kadosh and Struhl, 1997, 1998; Rundlett et al.,
1998); and (2) the Isw2, which has chromatin remodeling
activity (Fazzio et al., 2001; Goldmark et al., 2000). Upon
transfer to meiotic conditions, the repression activity is
abolished and the expression and function of Ime1, the
master activator of meiosis, is induced (Covitz and Mitchell,
1993; Sagee et al., 1998; Sherman et al., 1993). IME1
encodes a transcription factor that activates expression of
early meiotic genes such as IME2 or HOP1, which are
required for expression of middle and late genes and for
chromosome synapsis and meiotic recombination, respec-
tively (Guttmann-Raviv et al., 2002; Mitchell et al., 1990;
Vidan and Mitchell, 1997; Yoshida et al., 1990). As in the
case of the repressor complex, Ime1 does not bind DNA
directly but rather is recruited to the promoter of the early
meiotic genes via Ume6 (Rubin-Bejerano et al., 1996).
Given the evolutionary conservation of the meiotic
process itself, we hypothesized that key genes regulating
the transition from mitotically dividing cells to meiosis in
yeast might have functional evolutionarily conserved
counterparts in mammals. This hypothesis was further
supported by the fact that a SIN3–RPD3-dependent
regulation of gene expression exists in mammals as well
(Ayer et al., 1995; Kasten et al., 1996; Taunton et al., 1996).
In this study, we took a functional complementation
approach in which we searched for mouse genes that would
activate promoters of yeast early meiotic genes. Using this
approach, several mouse genes were cloned, one of which is
a novel gene that we designated Aym1.Materials and methods
Source of tissues
Balb/c mice, N60 days of age, were used as a source of
normal adult mouse tissues for all experiments. For
developmental studies, embryos were dissected from preg-
nant females at specific days of gestation (formation of
vaginal plug is designated d0.5 of gestation), and neonatal
testes were collected from animals at days 7–21 of postnatal
development (day of delivery is designated d1). All animals
were sacrificed by cervical dislocation. Tissues for RNA
extraction were frozen in liquid nitrogen immediately upon
dissection and stored at 708C until used. Tissues for
paraffin sections, used for both in situ hybridization and
immunohistochemistry analysis, were fixed overnight in 4%
paraformaldehyde (48C) in phosphate-buffered saline pH
7.4 (PBS), washed with PBS and saline for 30 min,incubated sequentially in 50% and 70% (2) ethanol in
saline for 30 min each and stored at 70% ethanol (48C) until
used for paraffin impregnation and block formation. For
whole-mount in situ experiments, embryos at various days
of gestation (10.5, 12.5, 13.5, and 14.5) were fixed
overnight in 4% paraformaldehyde (48C) in PBS, washed
twice in PBT (0.1% Triton X-100 in PBS), and dehydrated
in increasing methanol concentrations (25%, 50%, 75% in
PBT and twice in 100%) for 10 min each. Embryos were
stored at 100% methanol (208C) until used. All animal
procedures complied with all relevant institutional policies
and guidelines.
Library construction, reporter yeast strains, and genes for
screening
An expression library was constructed from pooled poly
A+ RNA extracted from testes of two adult mice. The library
was constructed in the pGAD-Rx shuttle vector (Stratagene)
according to the manufacturer’s instructions such that the
inserts were expressed as fusion proteins with the Gal4
activation domain (AD). All library plasmids contained the
LEU2 and Amp genes as selectable markers for yeast and
bacteria, respectively. For the screening, we used the Y1075
(MATa, ura3-52, leu2-3,112, trp1D, his3DhisG, ade2-1,
GAL+, CANs, met gal80DhisG, gal4DhisG, ime1DhisG)
and Y1076 (MATa, ura3-52, trp1D, leu2-3,112, his3DhisG,
ade2-R8, GAL+, CAN s gal80DhisG, gal4DhisG,
ime1DhisG) haploid S. cerevisiae yeast strains. The HIS3
or lacZ reporter genes, linked to the IME2 promoter (pIME2-
HIS3 or pIME2-lacZ), were used for selection and screening,
respectively. Strain Y10752L: The pIME2-lacZ construct
was integrated at the URA3 loci of strain Y1075 via
homologous recombination following transformation with
YIp1387 digested with StuI, selecting for URA+. YIp1387
carries the pIME2-lacZ chimera on a URA3 vector (Mandel
et al., 1994). Y10762H: The pIME2-HIS3 construct was
integrated at the URA3 loci of strain Y1076 via homologous
recombination following transformation with YIp1996
digested with StuI selecting for URA+. YIp1996 carries the
pIME2-HIS3 chimera on a URA3 vector. This plasmid was
constructed in two steps: (1) a 960-bp XhoI–HindIII frag-
ment carrying the IME2 promoter (23 to 983), was
digested from the pSP1 plasmid (Yoshida et al., 1990) and
ligated to the corresponding restriction sites in the pRS406
URA3 vector (Sikorski and Hieter, 1989); (2) a 737-bp PCR-
derived EcoRI–HindIII fragment carrying the HIS3 gene
(7 to +703) was ligated to the corresponding restriction
sites in the pRS406 URA3 vector described above. Genomic
DNA was used for the PCR reaction and the primers
consisted of forward 5V CGGAATTCCGGGCAAGA-
TAAACGAAGGC 3V and reverse 5V CGGGATCCCGTA-
TATCGTATGCTGCAGC 3V. The Y10752L and Y10762H
cells were selected by Uracil-depleted medium. An addi-
tional yeast strain that was used in control experiments for
the lacZ assay was Y190 (MATa, ura3-52, his3-200, ade2-
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GAL1UASGAL1TATAlacZ). Other plasmids that were used
include YEp1240 for constitutive expression of Ime1,
YEp2042 for expression of lacZ under the regulation of
the HOP1 promoter, and YIp1583 to knockout the UME6
gene by homologous recombination.
LacZ assay
For qualitative analysis, we either grew the cells on SA-
X-Gal plates (yeast nitrogen base without amino acids
0.27%, ammonium sulfate 0.5%, l-Thr 0.34%, l-Tyr
0.004%, KAc 1%, casamino acids 0.2%, adenine 0.004%,
tryptophan 0.005% agar 1.8%, and X-gal added to a final
concentration of 0.1 mg/ml) for 2–3 days and monitored for
the development of blue colonies or performed a filter lift
assay. For the filter assay, yeast colonies to be tested were
grown on SD medium for 3–7 days (308C) and then
replicated onto a No.1 Whatman filter paper (8.5 cm in
diameter). Cell walls were perforated by submerging the
filters in liquid nitrogen for 5–10 s and immediately thawing
them in the air. Filters were then laid upon a second No. 1
Whatman filter paper placed in a Petri dish and adsorbed
with Z buffer (Na2HPO4 0.06 M; NaH2PO4 0.04 M; KCl
0.01 M; MgSO4 0.001 M) containing 0.27% h-mercaptoe-
thanol and X-gal in a final concentration of 334 Ag/ml. The
plates were sealed and incubated at 308C until blue color
developed (usually 10–180 min). For quantitative analysis,
cells were grown in liquid SD medium to a concentration of
about 107 cells/ml, cooled on ice for 2 min, centrifuged 5
min at 440  g and the supernatant discarded. Cells were
resuspended in 250 Al breaking buffer (Tris pH 8 100 mM;
DTT 1 mM; glycerol 20%) containing 1.9 mM phenyl-
methylsulfonylfluoride (PMSF, Sigma) and were vortexed
several times at highest speed with an approximately equal
volume of 0.45-mm glass beads to break the cells. An
additional aliquot of 250 Al breaking buffer was added to the
solution, mixed, centrifuged, and 100 Al of clear supernatant
was transferred to 900 Al of Z buffer and incubated 5 min at
288C. To start the colorimetric reaction, 0.2 ml of o-
nitrophenyl-h-d-galactoside (ONPG, Sigma) solution (from
stock of 4 mg/ml) was added and the reaction was incubated
at 288C until yellow color developed. The reaction was
stopped by the addition of 0.5 ml Na2CO3 from a stock
solution of 1 M, and the optical density of the solution was
measured at 420 nm. The specific activity, in units of nmol
min1 mg1 protein, was calculated by the following
formula: 1.7  OD420 / T  V  C  0.0045, where T is
time (min), V is volume of added extract (ml), and C is the
total protein concentration of the extract (mg/ml).
PCR and RT-PCR analysis
PCR reaction mix (total volume 50 Al) consisted of 10 or
100 ng of plasmid or genomic template DNA, respectively,5 Al of 10 PCR buffer (TaKaRa), dNTPs 50 AM each, 20
pmol of each primer, and 2.5 units of Taq polymerase
(TaKaRa). Mineral oil (50 Al) was laid upon the reaction
mix, and the PCR program was adjusted specifically for
each experiment. For reverse-transcription PCR (RT-PCR),
total RNA was extracted from various tissues by standard
procedures using Tri reagent (Sigma) and 400–500 ng RNA
was used with the Ready-To-Gok RT-PCR beads (Amer-
sham-Pharmacia) according to the manufacturer’s protocol.
Primers were designed to flank the coding region of Aym1.
The forward primer was 5V-TCCCTGTCTAGCAAT-
GAAGC-3V and the reverse primer was 5V-GAGGGGG-
CATGTTTTAGGAT-3V. Each RT-PCR reaction contained,
in addition, commercial consensus primers for the 18S
ribosomal RNA (Quantum RNA Classic 18Sk, Ambion) to
be used as an internal control. The intensities of the 18S
rRNA bands were compared densitometrically and each
Aym1 band was normalized to its own 18S rRNA before the
intensity of the Aym1 bands was compared.
In situ hybridization
In situ hybridization analysis was performed as previ-
ously described (Don and Wolgemuth, 1992). In short,
paraffin sections, 5-Am thick, underwent deparaffination
with xylene, rehydration with decreasing ethanol concen-
trations (100%, 95%, 85%, 70%, 50%, and 30%, 2 min
each), 0.85% saline and PBS washes (5 min each),
postfixation in 4% paraformaldehyde (20 min), PBS washes
(5 min, 2), proteinase K treatment for 8 min (20 Ag/ml in 5
mM EDTA, 50 mM Tris–HCl pH 7.5), PBS wash (5 min),
refixation in 4% paraformaldehyde (5 min), incubation in 0.1
M triethanolamine pH 8.0 with acetic anhydride added to
0.25%, PBS and 0.85% saline washes (5 min each), and
dehydration in increasing ethanol concentrations (50–95%, 2
min each and 2 min in 100%, 2). [a35S]UTP-labeled Aym1
antisense RNA (synthesized from the entire cDNA) was used
as a probe and a sense RNA probe was used as a negative
control. Hybridization mix consisted of 0.6 M NaCl, 0.12 M
Tris (pH 8.0), 0.008 M EDTA (pH 8.0), 2 Denhardt’s
solution (Sigma), 10% dextran sulfate, yeast total RNA
(Sigma) (100 Ag/ml), sheared and denatured salmon sperm
DNA (100 Ag/ml), 50% formamide, 10 mM DTT, and 0.1%
SDS and hybridization was performed overnight in a humid
chamber at 508C. After hybridization, slides were washed as
follows: formamide wash (50% formamide, 1 SSC, 10 mM
DTT) for 30 min at 508C; 0.5 SSC (30 min at RT); 20 Ag/
ml RNase A in 3.5 SSC (30 min at RT); 3.5 SSC (2 10
min each at RT); 0.1 SSC (2 h at 658C). Slides were
dehydrated in increasing ethanol concentrations (50%, 75%,
and 95%) in 0.3 M sodium acetate (pH 5.5), 2 min each, and
15 s in 100% ethanol. Slides were dipped in LM-1k
emulsion (Amersham Pharmacia), exposed for about 2
weeks, developed, and counterstained with hematoxylin.
Sections were examined using bright and dark field optics
using an Olympus photomicroscope.
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Fixed embryos were hydrated in decreasing methanol
concentrations (75%, 50%, 25% in PBT and twice in PBT)
for 10 min each. Embryos were then incubated in 6% H2O2
in PBT, washed in PBT (3, 5 min each), incubated in 10
Ag/ml proteinase K in PBT (45 min at 378C) and in 2 mg/ml
glycine in PBT (10 min), washed in PBT (2, 5 min each),
refixed in a solution containing 4% paraformaldehyde and
0.1% glutaraldehyde in PBT, and washed three times in PBT
(5 min each). Samples were then transferred to hybridization
buffer [50% formamide, 1.3 SSC, 5 mM EDTA, 50 Ag/ml
yeast total RNA, 0.2% Tween-20 and 0.5% CHAPS
(Sigma), 100 Ag/ml heparin] and incubated for 1 h in
708C before 1 Ag DIG labeled Aym1 probe (DIG RNA
labeling mix; Roche) was added and incubation persisted
overnight at 708C. Washes consisted of solution I (50%
formamide, 5 SSC, 1% SDS) for 30 min at 708C (3);
solution II (50% formamide, 2 SSC) for 30 min at 708C
(3); 2 mM levamisol (Sigma) in Tris-buffered saline
containing 0.05% Tween-20 (TBST) for 5 min at RT (3);
100 Ag/ml RNase A in PBST for 10 min at RT; 2 mM
levamisol in TBST for 5 min at RT (3); and solution III
(0.15 M NaCl, 0.1 M Tris pH 7.5, 2 mM levamisol) for 10
min at RT. Samples were blocked overnight in 2% blocking
solution (Roche) diluted in solution III and containing 20%
fetal calf serum (FCS). Embryos were then incubated
overnight with anti-DIG antibodies, according to the
manufacturer’s protocol (Roche), washed in TBST over-
night (48C) and then in NTMT solution (NaCl 0.1 M, Tris
0.1 M pH 9.5, MgCl2 0.05 M, 1% Tween-20) containing 2
mM levamisol for 10 min (3). Colorimetric reaction was
performed by incubating the samples in NTMT solution
containing 3.5 Al/ml BCIP and 4.5 Al/ml NBT (Sigma).
Antibody production
Polyclonal antibodies were raised in rabbits against the
synthetic peptide EDALVPLSLRERSTRTAR comprising
amino acids 11–28 of the putative AYM1 peptide, and
affinity purified according to standard procedures
(ResGenk, Invitrogen). This peptide shows no homology
to any known mouse peptides nor to any potential peptide
based on the complete mouse genomic sequence. ELISA
analysis, with the synthetic peptide as antigen, and Western
blotting on protein extracts of E. coli (BL21), expressing
His-tagged AYM1, were used to verify affinity and
specificity of the purified antibodies to the AYM1 peptide
(see Results).
ELISA
ELISA plates (Nunc) were coated with 100 Al PBSE
(137 mM NaCl, 1.5 mM KH2PO
4, 8 mM Na2HPO4 
12H2O, and 0.2% NaN3) containing 1 Ag recombinant 6 his-
tagged AYM1, and incubated at 378C for 2 h. Plates werewashed twice with PBSE, blocked with 0.2% gelatin for 70
min at 378C, and washed five times with PBST (PBSE
containing 0.05% Tween 20) before the addition of 100 Al
rabbit anti-AYM1 serum at various dilutions and incubation
for 1 h at 378C. Alkaline phosphatase (AP)-conjugated anti-
rabbit IgG (Promega) was used as a second antibody
(dilution 1:2000 in PBST) for 2 h at 378C. Following five
PBST washes, 200 Al AP substrate solution was added,
plates incubated 45 min at 378C, and the reaction stopped by
the addition of 50 Al NaOH (3 M). Color development was
recorded by an ELISA reader at 405 nm.
Immunoprecipitation and immunoblotting
Proteins were extracted from testes of mature male mice
according to standard procedure. For immunoprecipitation,
500 Ag total proteins were brought to a final volume of 2 ml
in PBS, containing 0.55% Triton X-100, and incubated with
20 Al of protein A/G PLUS agarosek (Santa Cruz
Biotechnology) for 1 h at 48C. The protein A/G agarose
beads were then removed by centrifugation and 5 Ag anti-
AYM1 antibodies were added to the supernatant and
incubated overnight at 48C. Next, the protein–antibody
mixture was incubated with 30 Al protein A/G agarose beads
for 6 h at 48C under gentle agitation. The beads were then
washed five times with PBS, boiled 5 min in 2% SDS (25
Al) before loading buffer was added. The samples were
separated on a 15% polyacrylamide gel using Tris–Tricine
buffer (Bio-Rad) as running buffer. The separated proteins
were blotted onto a PROTRAN BA83 cellulosenitratek
membrane (Schleicher & Schuell), which was incubated in
blocking solution, containing 10% skim milk in TBST (20
mM Tris–HCl pH 7.5, 150 mM NaCl, 0.05% Tween 20), for
1 h at room temperature. Anti-AYM1 antibodies (diluted
1:20,000 in TBST), as first antibody, and HRP conjugated
anti-rabbit IgG antibodies (Promega, diluted 1:2000 in
PBST) were used for detection using the SuperSignal West
Pico Chemiluminescent Substratek (Pierce).
Immunohistochemistry
Sections of paraffin-embedded tissue (approximately 5-
Am thick) were deparaffinized in xylene for 20 min,
rehydrated in decreasing ethanol concentrations (100%,
95%, 70%, 50%, 2 min each), and washed in H2O for 10
min. Slides were transferred to 0.01 M sodium citrate (pH
6.0), heated to boiling in a microwave oven at maximum
intensity for 2 min, and then at 20% intensity for an
additional 13 min. After cooling down at RT for 15 min,
slides were washed in PBS for 2 min (2), and then blocked
for 1 h in 20% normal goat serum and 0.1% Triton X-100 in
PBS. Primary antibody (rabbit anti-AYM1) diluted 1:20 in
blocking solution was applied to the sections at room
temperature for 1 h (alternatively, overnight at 48C) and then
removed by three washes in PBST, 15 min each. Alexa-488-
conjugated goat anti-rabbit IgG antibody (Molecular
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was used as a second antibody (1 h in the dark, at RT)
followed by two washes in PBS–Tween (10 min). Nuclei
were stained for 3 min with propidium iodide, and the
sections washed twice in PBS–Tween (15 min). One drop of
bleaching retardant (Bio-Rad) was added to the sample
before sealing with a cover slip. Sections were viewed with
the MRC 1024 confocal microscope (Bio-Rad) using an
argon/krypton laser. Excitation was at 488 nm for Alexa-488
and at 568 nm for PI.Results
Cloning of Aym1
We searched for mouse genes that would functionally
complement the ability to activate yeast early meiotic
promoters in ime1 mutant yeast cells. For this search, we
constructed the Y10762H and the Y10752L strains able to
express the HIS3 gene and the lacZ gene, respectively,
under the regulation of the IME2 promoter. No growth of
the Y10762H cells could be detected on Leu, Trp, or His
depleted medium containing acetate as a carbon source (Fig.
1A). Likewise, Y10752L cells exhibited negative results in a
lacZ assay. However, when IME1 was ectopically expressed
in these cells, growth of Y10762H cells was observed on
-His acetate medium (Fig. 1A) and moderate blue color was
apparent in Y10752L cell colonies on SA-X-Gal plates.
These results indicated that Ime1 indeed activated the
expression of the reporter genes via the IME2 promoter
and that no activation occurs in the absence of Ime1. A
mouse testis expression library, in which mouse testicular
peptides were fused to the Gal4 activation domain, wasFig. 1. (A) Selective growth of the constructed yeast strains (a–g) on
different selection media (marked at the top of each plate) used for the
functional cloning of Aym1. (a) Y1076 cells that contain neither the pIME2-
HIS construct (pIME2-HIS) nor a library plasmid expressing the AD–
AYM1 fusion protein (AD–AYM1) nor a Leu+ plasmid expressing Ime1,
(Ime1); (b) Y1076 cells, which are (pIME2-HIS), (AD–AYM1)+, and
(Ime1); (c) Y10762H cells, which are (pIME2-HIS)+, (AD–AYM1), and
(Ime1); (d) Y10762H cells, which are (pIME2-HIS)+, (AD–AYM1), and
(Ime1), but include a library plasmid with an irrelevant insert; (e)
Y10762H cells, which are (pIME2-HIS)+, (AD–AYM1), and (Ime1)+; (f)
Y10762H cells, which are (pIME2-HIS)+, (AD–AYM1)+, and (Ime1); (g)
Y10762H/Y10752L (MATa/a) diploid cells including the (pIME2-lacZ)
and (pIME2-HIS) constructs, expressing the AD–AYM1 fusion protein and
an additional Trp+ plasmid originating from the Y1075, and which are
(Ime1). (B) Filter lift assay demonstrating the ability of AD–AYM1 to
activate the yeast HOP1 promoter and hence the LacZ reporter. IME1 was
used as a positive control for activation of the HOP1 promoter and Gal4
was used as a positive control for the lacZ assay in Y190 cells. Y1076 cells,
transformed with either the pHOP1-LacZ or the AD–AYM1 plasmids alone
as well as cells co-transformed with pHOP1-LacZ and the Gal4-AD, were
used as negative controls. (C) Activation of the HOP1 promoter by AD-
AYM1 is Ume6-dependent. Activation of the HOP1 promoter was
determined in ume6A¨ cells in comparison to UME6 cells. IME1 was used
as a positive control for activation of the HOP1 promoter and Gal4 was
used as a positive control for the lacZ assay in Y190 cells.constructed and introduced into the Y10762H cells. Trans-
formed cells where plated onto -Leu-His plates to select for
cells containing a library plasmid in which the HIS3 gene
was activated through the IME2 promoter. This screen
resulted in 28 colonies. To ensure that growth was due to a
specific mouse clone, plasmids were purified from each
positive clone and purified plasmids were then used to
retransform Y10762H cells. Fifteen colonies grew on -Leu,
-His plates. To further verify that colony growth was indeed
the result of activation of the IME2 promoter, rather than
suppression of the his3 mutation, cells from the 15 positive
colonies were mated with Y10752L cells containing an
additional plasmid conferring selection of diploids on -Trp
plates. After mating, cells were plated on -Ura, -Leu, -His,
and-Trp plates and the growing colonies were assayed for h-
galactosidase activity. Six colonies developed blue color
(double positive), indicating activation of the IME2 pro-
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protein. Primary sequence analysis of plasmids from all
six double-positive clones revealed that three of them
(clones 13, 17, and 21) were identical and represented a
novel murine gene, which we designated Aym1 (activates
yeast meiotic promoters). Three other clones were found to
be identical to the previously cloned Spz1 (clone 4) and
Tctex2 (clones 9 and 26) mouse genes (Hsu et al., 2001;
Huw et al., 1995) and will be further characterized in
subsequent communications.
Activation by the AD–Aym1 fusion protein is not restricted
to the IME2 promoter
The results described above show that the fusion protein
Gal4AD–AYM1 is able to activate expression of a reporter
gene from the meiosis specific IME2 promoter. Can this
fusion protein activate promoters of other early meiotic
genes? To address this question, we tested the ability of our
AD–AYM1 fusion protein to activate the promoter of the
HOP1 gene. To this end, the original Y1076 cells were
cotransformed with the AD–AYM1 plasmid and a plasmid
carrying the lacZ reporter gene under the regulation of the
HOP1 promoter (pHOP1-lacZ). After selecting for cells that
contain both plasmids (Trp+, Leu+), we consistently obtained
lacZ-positive colonies, as in the case of the positive control
where an Ime1-expressing plasmid was cotransformed with
the pHOP1-lacZ construct (Fig. 1B). No blue color devel-
oped in the original Y1076 cells, when the AD–AYM1 fusion
protein was expressed alone or when the reporter plasmidwas
expressed either alone or together with the GAL4-AD. It is
important to mention that when the AD–AYM1 fusion
protein was expressed in an additional yeast strain, Y190,
in which the lacZ gene appears under the regulation of the
nonmeiotic GAL1 promoter, no blue color developed beyond
background, suggesting that the AD–AYM1 fusion protein
specifically activated the HOP1 and IME2 promoters. This
suggests that activation by the AD–AYM1 fusion protein is
not restricted to the IME2 promoter, but rather seems to be
more general to promoters of early meiotic genes.
Activation of the HOP1 promoter is Ume6 dependent
Ume6, a DNA-binding protein, is a key molecule in the
regulation of expression of yeast early meiotic genes. It acts
as a mediator through which the Sin3–Rpd3 complex
represses expression under vegetative conditions, and
Ime1 activates expression under meiotic conditions. To test
whether Ume6 is necessary for the activation of the meiotic
promoters by the AD–AYM1 fusion protein, we knocked-
out the UME6 gene in our original Y1076 cells by using a
construct that contained the URA gene flanked by UME6
sequences to facilitate homologous recombination. Selected
URA+ colonies were transformed with the pHOP1-lacZ
construct and a plasmid expressing AD–AYM1, or alter-
natively Ime1, and a quantitative assay for h-galactosidaseactivity was performed. About a 1000-fold decrease in h-
galactosidase activity was observed in ume6D cells express-
ing Ime1 in comparison to UME6 cells, indicating that Ime1
cannot activate the HOP1 promoter in these ume6D (null)
cells (Fig. 1C). An approximately 10-fold decrease in h-
galactosidase activity was recorded in ume6D cells express-
ing the AD–AYM1 fusion protein, compared to UME6
cells, restoring the h-galactosidase activity to background
levels (Fig. 1C). These results suggest that AD–AYM1
activated the HOP1 promoter in an Ume6-dependent
manner. Nonetheless, we were not able to demonstrate
direct interaction between AYM1 and Ume6 in a two-hybrid
analysis using the Ume6 protein as bait (data not shown).
This might suggest that AYM1 interacts with an additional
protein present on the Ume6 complex.
Despite the fact that the AD–AYM1 fusion protein was
able to activate some early meiotic genes in a manner similar
to Ime1, we were not able to rescue the sporulation process in
ime1 mutant yeast strains by expression of the AD–AYM1
protein, even under meiotic and sporulation conditions. This
suggests that Ime1 has functions beyond those of AD–
AYM1. Moreover, AYM1 by itself could not activate
expression, as shown in a two-hybrid screen when it was
used as bait, in the form of a Gal4BD–AYM1 fusion protein
(data not shown). This suggests that AYM1 lacks an
independent transactivation activity and hence Aym1 by
itself does not appear to be a functional homologue of IME1.
The Aym1 gene
To obtain a full-length cDNA of Aym1, we used the
Aym1 insert from clone 13 as a probe to screen a mouse
testis cDNA library (Stratagene). Three independent clones,
consisting of identical sequences, were obtained revealing
that the putative complete Aym1 cDNA consists of 534 bp
(GenBank accession number AF069744), including a 138-
bp-long reading frame that presumably encodes a short
peptide of 45 amino acids. No consensus functional motifs
were found in this short peptide using various searching
methods. Aym1 is located on mouse chromosome 5 at
chromosomal band 5qF, which contains three additional
Aym1-related sequences on the complementary strand
within a range of 26 kb. Using the hybrid polymorphism
method, we mapped Aym1 to mouse chromosome 5, about
65 cM from the centromere (not shown). Interestingly,
Aym1 mapped near the jg mutation, which when homo-
zygous, confers sterility and body formation abnormalities
in male mice and significantly reduced fertility in females
(Jackson Laboratory’s records). Nonetheless, sequence
analysis of genomic DNA from jg mutant mice (Jackson
Laboratory) revealed no mutations in the Aym1 gene (not
shown). Comparison between the cDNA sequence and the
genomic sequence of Aym1 revealed that Aym1 is an
intronless gene. A search through databases of several
published complete genomes, including fly, C. elegans,
zebra fish, and human, did not reveal obvious orthologs.
Fig. 3. RT-PCR analysis, using primers flanking the coding region of Aym1,
of total RNA (100 ng/sample) from (A) seven adult mouse tissues including
testis—T; epididymis—Ep; heart—H; kidney—K; liver—Li; brain—B; and
spleen—S. PCR reaction consisted of 35 cycles. Primers for the 18S rRNA
were used under identical reaction conditions as internal controls, but run
for 26 cycles only. (B) Testes of pups at different postnatal (pn) ages.
Primers for the 18S rRNA were used in the same reaction as internal
controls. For quantitative comparison of Aym1 expression at different pn
ages, the intensity of the Aym1 signal in each sample was defined as the
percent of the intensity of its normalized internal control. The relative
expression intensities are presented in a histogram.
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3VUTR of the Aym1 cDNA, which flank the coding region
(forward-CCCCTCCCTGTCTAGCAATGAAGCCCCGTG
and reverse-CATTTACTTATTCCCTGAACTACCT-
GAGCA) in a PCR analysis of human genomic DNA, we
obtained a band with a sequence highly similar to that of the
mouse Aym1 (GenBank accession number AY217092). The
two sequences differ in only four nucleotides conferring
three conservative amino acid changes: T24 to R, R25 to H,
and T31 to S (Fig. 2). These results support the existence of a
human Aym1 ortholog, which is apparently in a gap within
the current human genome sequence.
Aym1 expression in mouse
Northern analysis of 8 Ag poly A+ RNA from different
mouse tissues, using the entire Aym1 cDNA as a probe,
revealed a consistent although very faint signal of about 0.7
kb only in the testis (data not shown), indicating a very
modest level of expression of this gene. The size of this
transcript is consistent with a cDNA of 534 bp that lacks the
poly A tail. Tissue survey of Aym1 expression using RT-PCR
analysis revealed unique abundance of transcripts in the
testis compared to all other tissues tested (Fig. 3A). Minute
amounts of Aym1 transcript were detected in liver, brain, and
spleen as well. Primers for 18S ribosomal RNAwere used as
an internal control to normalize for quantity and to assess the
quality of the RNA taken for the RT-PCR analysis.
One way to trace the testicular developmental stage at
which a gene is expressed is by analyzing RNA samples
extracted from testes of pups at different postnatal (pn) ages.
Primary spermatocytes from the first spermatogenic wave
reach the leptotene stage of prophase I at pn d10. By pn d12,
zygotene spermatocytes are present and by pn d14 and 17
spermatocytes from the first spermatogenic wave reach the
early and late pachytene stage, respectively. Haploid round
spermatids first appear at about pn d21 (Bellve et al., 1977;
Malkov et al., 1998). RT-PCR analysis was performed on
RNA samples from testes of pups at different postnatalFig. 2. Sequence comparison between the mouse and the human Aym1 ORF. The t
conservative amino acid changes.developmental stages (pn day 7, 10, 12, and 17), and a
densitometric comparison of the Aym1 bands (normalized
based on the 18S internal control) was performed. As can be
seen in Fig. 3B, a significant increase in the amount of
Aym1 transcripts was apparent at pn d10 correlating with
cells from the first spermatogenic wave entering prophase I
of the meiotic division. The level of Aym1 transcripts
peaked at pn d17 and declined thereafter. These results
suggest that Aym1 transcripts accumulate as the primary
spermatocytes enter prophase I, and transcription is down-
regulated once meiosis has been completed.wo sequences differ in only four nucleotides (shaded boxes) conferring three
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testis that express Aym1 and the developmental stages at
which this gene is expressed, we performed in situ hybrid-
ization analysis on testis sections from normal mature males,
as well as from the at/at germ cell deficient mutant strain of
mice (Hummel, 1966). Within the normal mature semi-
niferous tubules, signal appeared only over primary sperma-
tocytes and in a spermatogenic cycle-dependent manner
(Fig. 4). Tubules at stages V–XI of the spermatogenic cycle
express Aym1 more abundantly than tubules at stages I–IV.
Signal could not be seen over interstitial regions that consist
of testicular somatic cells, mainly Leydig cells. In addition,
no signal above background was detected in sections from
the at/at mutants (not shown). These results agree with our
RT-PCR results and indicate that within the testis, Aym1
expression is restricted to primary spermatocytes.
Is Aym1 expressed specifically during spermatogenesis or
is it important for the more general process of meiosis? If
Aym1 is a meiotic rather then a spermatogenic specific gene,
it should be expressed in the comparable meiotic stages in
the female. Primary oocytes enter the meiotic division during
embryonic development. At about 14 days of gestation,
primary oocytes enter meiotic prophase. Leptotene and
zygotene stages may be seen at 14.5 and 15.5 days of
gestation and by 16–17 days of gestation pachytene oocytes
appear (Rugh, 1968). To address this issue, whole-mount in
situ experiments were performed on embryos of 10.5, 12.5,
13.5, and 14.5 days of gestation. These experiments revealed
that five out of ten 13.5d embryos showed gonadal specificFig. 4. In situ hybridization analysis of a testis section from normal adult mouse us
give an overview under low magnification. Stages of the spermatogenic cycle are
(bright and dark field, respectively) of the framed region shown in panel A. Scalsignal (Fig. 5A). No signal was obtained in embryos at
earlier stages or in embryos 14.5 days of gestation. To
determine the gender of all analyzed embryos, DNA was
extracted from tails of the embryos and analyzed by Southern
blotting using the Y353/B mouse Y-chromosome-specific
probe (Bradbury et al., 1990). All the DNA samples taken
from the embryos that gave a positive signal in the whole-
mount analysis were found to be females whereas all the
negatively reacting d13.5 embryos were found to be males
(Fig. 5B). These results indicate that Aym1 is indeed a
meiotic gene that is expressed at the onset of prophase I. We
believe that the reason why embryos at d14.5 of gestation did
not display any hybridization signal, although some of the
embryos were females, was probably due to low diffusion of
the probe into these rather large embryos.
Immunodetection and immunolocalization of AYM1
Given the fact that Aym1 shows no homology to any
known sequences and that its putative peptide does not
contain any known functional domains, it was not obvious
that it is translated at all. Antibodies were raised against a
synthetic peptide comprising amino acids 11–28 of the
putative AYM1 peptide. ELISA analysis was used to
demonstrate the high affinity (dilution of 1:20,000 still gave
an O.D. of 0.8) and specificity of our antibodies (Fig. 6A).
This specificity was supported by Western blotting on
protein extracts of E. coli expressing His-tagged AYM1
(Fig. 6B). No such signal appeared using a protein extracting Aym1 antisense RNA as probe. Panels A (bright field) and B (dark field)
indicated in panel A. Panels C and D are higher-magnification micrographs
e bars indicate 50 Am.
Fig. 6. (A) ELISA analysis of anti-AYM1 antibodies. Different antibody dilutions
antibody (BSA/anti-BSA) served as a positive control. BSA-coated wells with our a
preimmune serum or without first or second antibody (AYM1/preimmune, AYM
analysis on protein extracts from E. coli containing the 6 His-tag expression plasm
which expression was not induced—UI; induced 6 His-tagged AYM1—I. M = mar
protein extract using anti-AYM1 antibody—A, preimmune serum—B, and protei
Fig. 5. (A) Whole-mount in situ hybridization of a 13.5d embryo, using an
Aym1 antisense probe labeled with DIG, and detected immunohistochemi-
cally by alkaline phosphatase. In the upper panel, the whole embryo is
shown at low magnification, and a gonad-specific signal is evident (box). In
the lower panel, higher magnification of the framed gonadal region is
shown. The signal outside the frame in the upper panel is an artifact of
puncturing the embryo at several sites to improve penetration of the
antibodies (arrow). (B) Southern blot analysis of genomic DNA obtained
from tails of analyzed embryos using the Y353/B mouse Y-chromosome-
specific probe. M—male, F—female.
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used for detection of the AYM1 protein by immunoprecipi-
tation and immunobloting from testicular protein extracts.
An expected signal of about 10 kDa was detected using our
antibodies, but not with preimmune sera (Fig. 6C), indicating
that AYM1 is indeed physiologically translated in the testis.
To further characterize the subcellular localization of the
protein, immunohistochemical staining was performed. In
testis sections from normal mature males, AYM1 immuno-
localized mainly to primary spermatocytes at the periphery
of the tubules (Figs. 7A–B). Moreover, in most cases, the
signal seemed to be colocalized with the PI staining of
nuclei, suggesting that it can enter the nucleus, although it
does not contain an established nuclear localization signal.
No staining was obtained in control experiments where anti-
AYM1 antibodies were preadsorbed with the synthetic
peptide, or when preimmune sera was used (not shown). In
addition, we could not detect an apparent signal over testis
sections from at/at germ cell-deficient mutant mice (Figs.
7C–D). Consistent with our RNA studies, these results
suggest that within the testis, AYM1 is predominantly
expressed in germ cells undergoing meiosis. This conclusion
was further supported by colocalization of AYM1 and
DMC1, an established meiotic gene (not shown).
Following the developmental pattern of Aym1 tran-
scription, as emerged from our RT-PCR analysis, we
examined, immunohistochemically, testis sections from
mice of various postnatal ages. No signal above background
could be observed in testis sections of pn d7 pups,were tested on AYM1-coated plates. BSA-coated wells with an anti-BSA
nti-AYM1 antibody (BSA/anti-AYM1), as well as AYM1-coated wells with
1/-I, AYM1/-II, respectively), were used as negative controls. (B) Western
id without an Aym1 insert—C; 6 His-tagged AYM1 expressing plasmid in
ker proteins (C) AYM1 immunoprecipitation from an adult mouse testicular
n A/G agarose beads with no antibody—C.
Fig. 7. Immunohistochemical analysis of the AYM1 peptide in paraffin sections of testes, at different developmental stages. Nuclei were stained with propidium
iodide (PI, red fluorescence), and AYM1 (green fluorescence) was detected using rabbit anti-AYM1 antibodies and Alexa-488 anti-rabbit IgG. Frames A, C, E,
G, I, K, M, and O demonstrate double staining, with PI and AYM1 localization images superimposed. Frames B, D, F, H, J, L, N, and P represent AYM1
localization. (A–B) adult testis; (C–D) germ cell-deficient mutant testis; (E–F) postnatal (pn) day (d)7; (G–H) pn d10; (I–J) pn d12; (K–L) pn d14; (M–N) pn
d17; (O–P) pn d20. Arrowheads indicate AYM1 expression in spermatogonia cells. Scale bar units are in Am.
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stage do not express AYM1 (Figs. 7E–F). As cells from the
first spermatogenic wave enter meiosis, at pn d10, leptotene
spermatocytes clearly express the AYM1 peptide (Figs. 7G–
H). At pn d12, AYM1 was immunolocalized mainly to the
cells at the periphery of the tubules, spermatogonia cells,
and to a lesser degree to the more centrally located zygotene
spermatocytes (Figs. 7I–J). At pn d14, the AYM1 signal was
significantly reduced and in some cases even close tobackground level (Figs. 7K–L). This is consistent with our
in situ hybridization results that suggested that very low
expression is attributed to early pachytene spermatocytes.
At pn d17, most pachytene spermatocytes exhibited nuclear
localization of AYM1 (Figs. 7M–N), and at pn d20, an
intense signal appeared over nuclei of late meiotic (mainly
diplotene) spermatocytes and possibly over secondary
spermatocytes as well (Figs. 7O–P). Most importantly, at
this stage of testicular development, spermatogonial immu-
Fig. 8. Immunohistochemical analysis of the AYM1 peptide in paraffin
sections of (A, B) ovary taken from a mouse embryo at d17.5 of gestation,
and (C, D) ovary taken from an adult female mouse. A and C demonstrate
double staining, with PI and AYM1 localization images superimposed. B
and D represent AYM1 localization. Scale bar indicates size in Am.
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wave of spermatogenic differentiation to commence. These
results suggest that AYM1 appears in three discrete stages
during spermatogenesis. It appears in a specific subpopula-
tion of spermatogonial cells, in leptotene primary sperma-
tocytes entering meiosis, and in the late stages of meiosis.
In the whole-mount experiments described above, we
demonstrated that Aym1 transcripts start to appear in the
gonadal region of day 13.5 gestation female embryos.
However, using this experimental approach, we were not
able to characterize the cell populations that expressed Aym1
within this region. To assess whether meiotic primary
oocytes are the cells predominantly expressing AYM1, we
immunostained sections from embryonic ovaries (day 17.5
of gestation) as well as from ovaries of mature females. In
embryonic ovaries, signal concentrated mainly in the nucleus
of what appear to be pachytene oocytes (Figs. 8A–B). In
ovaries of mature females, a rather intense nuclear signal was
detected in the diplotene meiotically arrested oocytes within
undeveloped follicles (Figs. 8C–D). These results are
consistent with our finding that AYM1 localizes to the
nucleus of pachytene (mainly late pachytene) and diplotene
spermatocytes, and strongly support our conclusion that
AYM1 plays a nuclear role in meiotically dividing cells.Discussion
Our understanding of the molecular mechanisms that
operate during differentiation of mitotically dividing sper-matogonia cells into spermatocytes lags well behind what is
known about other differentiative systems such as the
hematopoietic system. This is due mainly to the difficulty
in establishing an efficient in vitro system that could support
germ cell differentiation. This situation highlights the need to
find ways to establish appropriate cell lines or develop
alternative approaches to study the molecular mechanisms
regulating entry into and progression through meiosis.
Indeed, a recently established spermatogonial cell line (S4)
was reported to differentiate into meiotic spermatocytes and
thereafter into haploid cells upon treatment with stem cell
factor (Feng et al., 2002). Yet, another recently established
strategy to study germ cell differentiation is by spermatogo-
nia cell transplantation (review in Brinster, 2002).
In this study, we adopted a functional complementation
approach in an attempt to identify key mouse genes that
might be involved in the differentiative processes, leading
spermatogonia cells to enter meiosis. Given the high
evolutionary conservation of the meiotic process from yeast
to man, and given the increasing number of reports
demonstrating that genes regulating key biological pro-
cesses are functionally conserved along eukaryotic phylo-
genetic development (review in Kennedy, 2002), we
hypothesized that key molecules regulating entry into
meiosis in the yeast S. cerevisiae might have functional
counterparts in mammals. The fact that genes involved with
transcriptional regulation of yeast early meiotic genes, such
as the repressor SIN3 and the histone deacetylase RPD3,
have mammalian homologues (Ayer et al., 1995; Kasten et
al., 1996; Taunton et al., 1996) strengthened our rationale
for a functional approach to identify mice meiotic regu-
lators. Our screen was based on the ability of testicular
mouse proteins to activate promoters of yeast early meiotic
genes when fused to the Gal4 activation domain. In this
report, we showed that a Gal4AD–AYM1 fusion protein
(but not the Gal4AD alone) could activate both the HIS3
and the lacZ reporter genes via the meiosis-specific
promoter of the IME2 gene. We also demonstrated that this
activation is not restricted to the IME2 promoter, since other
meiosis-specific promoters, such as that of the HOP1 gene,
could be activated by the Gal4AD–AYM1 fusion protein as
well. The fact that this fusion protein could not activate the
lacZ reporter through the GAL1 promoter, which is not
involved in meiosis, suggests that AYM1 specifically
recognized, directly or indirectly, yeast early meiotic
promoters. Moreover, the observation that the recognition
between AYM1 and the yeast early meiotic promoters was
Ume6-dependent, suggests that AYM1 might be recruited
by one of the proteins forming the Ume6/Sin3/Rpd3/Isw2
repression complex or the Ume6/Ime1 activation complex.
Is AYM1 functionally related to yeast Ime1 or to any of
the additional proteins present in the large repression or
activation complexes? The answer to this question is
certainly not obvious, and at this stage we can only
speculate. Ime1 has two known functions. It is required
for both transcriptional activation and to relieve repression
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The observation that fusion of an activation domain to
AYM1 suffices for transcriptional activation (this report),
while fusion of an activation domain to Ume6 does not
(Washburn and Esposito, 2001), suggests that the AD–
AYM1 fusion protein may supply both functions. On the
other hand, expression of this fusion protein in ime1 mutant
cells was not sufficient to restore meiosis and sporulation,
suggesting that at best AD–AYM1 can only partially
compensate for the ime1 mutation.
Does Aym1’s expression pattern fit into a hypothesis that
AYM1 might play an Ime1-like function in the mouse? As
Ime1 activates early meiotic genes in the yeast, one would
expect that a related murine protein would be predom-
inantly expressed in testes and ovaries, and that within these
tissues it would be expressed at premeiotic stages of
gametogenesis. In our whole-mount in situ hybridization
analysis, we were able to demonstrate that Aym1 transcripts
appear in the gonad region of female embryos at day 13.5 of
gestation, a time compatible with cells being in premeiotic
stages. In males, we showed that Aym1 is predominantly
expressed in the testis. By in situ hybridization, we were
able to demonstrate that within the testis, Aym1 transcripts
were restricted to primary spermatocytes in tubule sections
at spermatogenic stages V–XI. However, using this in situ
hybridization analysis, we were not able to resolve whether
premeiotic spermatogonia cells and early meiotic prophase I
spermatocytes also express Aym1 transcripts. To this end,
testis sections of animals at different postnatal ages were
analyzed immunohistochemically. Our results demonstrated
that AYM1 appears in spermatogonial cells at pn d12 and
pn d20 where cells from the first spermatogenic wave reach
the zygotene and the diplotene stages of meiosis, respec-
tively (Bellve et al., 1977; Malkov et al., 1998). Specific
associations of spermatogonia cells, spermatocytes, and
spermatids, which are at a particular developmental stage,
characterize the spermatogenic cycle along the seminiferous
tubules (De Rooij, 1998; Russell et al., 1990). Since
according to the widely accepted cycle map of mouse
spermatogenesis, zygotene and diplotene spermatocytes are
associated at stage XI (Russell et al., 1990), we can attribute
spermatogonial expression of AYM1 to this stage. At stage
XI, the spermatogonia population consists of the undiffer-
entiated A(s), A(pr), and A(al) cells, which are present in all
other stages as well, and of the A3 differentiating
spermatogonia, which are specific to stages XI–XII
(Chiarini-Garcia et al., 2001; De Rooij, 1998). We
tentatively conclude, therefore, that A3 spermatogonia are
the dominant stage that expresses AYM1. Expression of
AYM1 in this population of spermatogonia ahead of
meiosis suggests that it might play a role in the differ-
entiation processes that leads to meiotic competence.
However, unlike Ime1, AYM1 lacks an independent trans-
activation activity. Nonetheless, the failure to activate
transcription in the yeast system does not rule out the
possibility that it might be a part of a modular complex thatcould activate transcription in mammalian cells (Kennedy,
2002). On the contrary, it is quite possible that the four
functions that are included in the yeast Ime1 protein
(nuclear localization, targeting to meiotic promoters, tran-
scriptional activation, and relief of Sin3/Rpd3 repression)
are divided between several mouse proteins, which would
increase the flexibility of such a regulatory system. Such a
hypothesis would be consistent with recent results we have
obtained, using the two-hybrid system, suggesting that the
AYM1 protein can interact with the LIM domain-containing
protein, FHL1 (data not shown). LIM domains are protein–
protein interaction motifs that are critically involved in
various developmental processes (Bach, 2000), and some of
them, especially the FHL family, were reported to be
engaged with transcriptional activation (Fimia et al., 1999,
2000; Muller et al., 2002; Ostendorff et al., 2002). Yet
another possibility is that AYM1 contributes to meiotic
competence by repressing genes, such as Oct-4, that must
be silenced before initiation of meiosis (review in Pesce et
al., 1998a,b). In males, Oct-4 is expressed in type A
spermatogonia but not beyond that stage. In females, Oct-4
expression is down-regulated coincident with entry into
meiosis so that it is present in 13.5 dpc oocytes but absent
in 15.5 dpc oocytes (Pesce et al., 1998a,b).
At present, any further predictions would be too
speculative. More definite conclusions must await further
studies elucidating the exact function of AYM1.Acknowledgments
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